XML 21 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Grant and collaboration revenue $ 349,344 $ 247,994 $ 663,908 $ 895,866
Operating expenses:        
Research and development 557,696 498,200 1,416,892 1,568,093
General and administrative 458,974 340,143 1,175,399 985,001
Total operating expenses 1,016,670 838,343 2,592,291 2,553,094
Loss from operations (667,326) (590,349) (1,928,383) (1,657,228)
Other income (expense):        
Interest income 1,058 1,592 4,092 3,249
Interest expense (625) (1,458)
Total other income (expense) 433 1,592 2,634 3,249
Net loss $ (666,893) $ (588,757) $ (1,925,749) $ (1,653,979)
Basic and diluted:        
Loss per common share (in dollars per share) $ 0 $ (0.01) $ (0.01) $ (0.03)
Weighted averages shares outstanding (in shares) 167,407,100 67,000,857 149,761,230 60,757,109